4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008750
Director bought 450,000 shares at $20.00 ($9,000,000)
- Director acquired 2,304,437 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HEALY JAMES Director | 2021-02-09 | Conversion | +1,104,209 | 1,104,209 | I: show line 1 in the form | ||
| HEALY JAMES Director | 2021-02-09 | Conversion | +1,200,228 | 2,304,437 | I: show line 2 in the form | ||
| HEALY JAMES Director | 2021-02-09 | Purchase | +450,000 | $20.00 | $9,000,000 | 2,754,437 | I: show line 3 in the form |
| Open-market purchases · 450,000 sh · avg $20.00 · $9,000,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HEALY JAMES Director | 2021-02-09 | Conversion · Series C-1 Preferred Stock | −1,104,209 | 0 | I: show line 4 in the form | ||
| HEALY JAMES Director | 2021-02-09 | Conversion · Series C-2 Preferred Stock | −1,200,228 | 0 | I: show line 5 in the form |
Loading xslF345X03/doc4.xml…